Literature DB >> 6404950

Incidence of infection with hepatitis B virus in 56 patients with haemophilia A 1971-1979.

M L Stirling, J A Murray, P Mackay, S H Black, J F Peutherer, C A Ludlam.   

Abstract

During each of the four-year periods 1971-1975 and 1975-1979, the annual incidence of hepatitis B infection has been assessed in 56 patients with haemophilia A by measuring plasma HBsAg, anti-HBs and anti-HBc levels. Infection rates of 7% and 9.5% per annum respectively were observed for each four-year period despite the screening of individual blood donations for HBsAg by techniques up to the sensitivity of reversed passive haemagglutination. The highest incidence of seroconversion was amongst severe haemophiliacs many of whom had received treatment predominantly with cryoprecipitate. Of the 16 patients in whom serological evidence of hepatitis B infection was obtained only one had an accompanying clinical episode of hepatitis. We conclude that haemophiliacs are still at high risk of infection by hepatitis B virus despite the screening of individual blood donors for HBsAg.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6404950      PMCID: PMC498290          DOI: 10.1136/jcp.36.5.577

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  13 in total

1.  Hepatitis antigen. Detection of infectious blood donors.

Authors:  D J Gocke; H B Greenberg; N B Kavey
Journal:  Lancet       Date:  1969-08-02       Impact factor: 79.321

2.  New human hepatitis virus.

Authors:  K N Tsiquaye; A J Zuckerman
Journal:  Lancet       Date:  1979-05-26       Impact factor: 79.321

3.  Evidence for existence of at least two types of factor-VIII-associated non-B transfusion hepatitis.

Authors:  J Craske; R J Spooner; E M Vandervelde
Journal:  Lancet       Date:  1978-11-11       Impact factor: 79.321

4.  Short incubation non-A, non-B hepatitis transmitted by factor VIII concentrates in patients with congenital coagulation disorders.

Authors:  M Bamber; A Murray; B A Arborgh; P J Scheuer; P B Kernoff; H C Thomas; S Sherlock
Journal:  Gut       Date:  1981-10       Impact factor: 23.059

5.  A tanned cell haemagglutination test for the detection of hepatitis-associated-antigen (Au-Ag) and antibody (anti-Au).

Authors:  R Hopkins; P C Das
Journal:  Br J Haematol       Date:  1973-11       Impact factor: 6.998

6.  Selection of plasma for hepatitis B immune globulin using a low cost radioimmunoassay.

Authors:  R Hopkins; S Ross; A Barr; D B McClelland
Journal:  Vox Sang       Date:  1981-01       Impact factor: 2.144

7.  Hepatitis and haemophilia therapy in Australia.

Authors:  K A Rickard; R G Batey; P Dority; S Johnson; J Campbell; J Hodgson
Journal:  Lancet       Date:  1982-07-17       Impact factor: 79.321

8.  Antibody to hepatitis B surface antigen in haemophiliacs on long-term therapy with Scottish factor VIII.

Authors:  C J Burrell; S H Black; D M Ramsay
Journal:  J Clin Pathol       Date:  1978-04       Impact factor: 3.411

9.  Evaluation of the effect of betapropiolactone/ultraviolet irradiation (BPL/UV) treatment of source plasma on hepatitis transmission by factor IX complex in chimpanzees.

Authors:  A M Prince; W Stephan; B Brotman; M C van den Ende
Journal:  Thromb Haemost       Date:  1980-12-19       Impact factor: 5.249

10.  Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States.

Authors:  W Szmuness; C E Stevens; E J Harley; E A Zang; W R Oleszko; D C William; R Sadovsky; J M Morrison; A Kellner
Journal:  N Engl J Med       Date:  1980-10-09       Impact factor: 91.245

View more
  1 in total

Review 1.  Blood safety and the choice of anti-hemophilic factor concentrate.

Authors:  Leonard A Valentino; Veeral M Oza
Journal:  Pediatr Blood Cancer       Date:  2006-09       Impact factor: 3.167

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.